TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment

E-ISSN： 1099-0895|34|1|dmrr.2941-dmrr.2941

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.34, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4‐1BB and OX40

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 2010-2020

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of TNF‐α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 303-6979, Iss. 9, 2015-09 ,pp. : 807-816

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of TNF‐α blocking on experimental periodontitis and type 2 diabetes in obese diabetic Zucker rats

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 42, Iss. 9, 2015-09 ,pp. : 807-816

John Wiley & Sons Inc

Access to resources Recommend Favorite

To die or not to die ? un modèle de la signalisation dichotomique de TNF-R1

By Micheau Olivier

Médecine/sciences, Vol. 20, Iss. 2, 2010-11 ,pp. : 153-155

Edp Sciences

Access to resources Recommend Favorite

Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes

By Ross Stuart A. Ballantine Jane

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1617-1626

Informa Healthcare

Access to resources Recommend Favorite